These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 15248293

  • 41. Reinduction of experimental autoimmune encephalomyelitis in mice.
    Lindsey JW, Pappolla M, Steinman L.
    Cell Immunol; 1995 May; 162(2):235-40. PubMed ID: 7538049
    [Abstract] [Full Text] [Related]

  • 42. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU, Bartlett RR.
    Drugs Exp Clin Res; 1997 May; 23(5-6):175-81. PubMed ID: 9515227
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R, Serna J, Perianes-Cachero A, Quintana-Portillo R, García-Seisdedos D, Canfrán-Duque A, Paino CL, Lerma M, Casado ME, Martín-Hidalgo A, Arilla-Ferreiro E, Lasunción MA, Pastor Ó.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [Abstract] [Full Text] [Related]

  • 46. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM, Freeman KG, Larson RD, Edwards GL, White LJ.
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [Abstract] [Full Text] [Related]

  • 47. Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
    Levy H, Assaf Y, Frenkel D.
    Exp Neurol; 2010 Nov; 226(1):148-58. PubMed ID: 20736006
    [Abstract] [Full Text] [Related]

  • 48. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [Abstract] [Full Text] [Related]

  • 49. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
    Lo AC, Saab CY, Black JA, Waxman SG.
    J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
    [Abstract] [Full Text] [Related]

  • 50. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R, Gerritsen W, Heijmans N, Amor S.
    Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
    [Abstract] [Full Text] [Related]

  • 51. GEMSP exerts a myelin-protecting role in the rat optic nerve.
    Mangas A, Vecino E, David Rodríguez F, Geffard M, Coveñas R.
    Neurol Res; 2013 Nov; 35(9):903-11. PubMed ID: 23816275
    [Abstract] [Full Text] [Related]

  • 52. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
    Onuki M, Ayers MM, Bernard CC, Orian JM.
    Microsc Res Tech; 2001 Mar 15; 52(6):731-9. PubMed ID: 11276125
    [Abstract] [Full Text] [Related]

  • 53. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R.
    J Autoimmun; 2014 Nov 15; 54():81-92. PubMed ID: 24934599
    [Abstract] [Full Text] [Related]

  • 54. Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Achiron A, Miron S.
    Mult Scler; 2000 Oct 15; 6 Suppl 2():S6-8; discussion S33. PubMed ID: 11188777
    [Abstract] [Full Text] [Related]

  • 55. The Anti-Inflammatory Effects of Oral-Formulated Tacrolimus in Mice with Experimental Autoimmune Encephalomyelitis.
    Kim MJ, Sung JJ, Kim SH, Kim JM, Jeon GS, Mun SK, Ahn SW.
    J Korean Med Sci; 2017 Sep 15; 32(9):1502-1507. PubMed ID: 28776347
    [Abstract] [Full Text] [Related]

  • 56. Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: heat shock protein 70 levels are modulated in microglial cells.
    Guzmán-Lenis MS, Vallejo C, Navarro X, Casas C.
    Neuroscience; 2008 Jul 31; 155(1):104-13. PubMed ID: 18577426
    [Abstract] [Full Text] [Related]

  • 57. Passive induction of experimental allergic encephalomyelitis.
    Stromnes IM, Goverman JM.
    Nat Protoc; 2006 Jul 31; 1(4):1952-60. PubMed ID: 17487182
    [Abstract] [Full Text] [Related]

  • 58. An electrophysiological model of spinal transmission deficits in mouse experimental autoimmune encephalomyelitis.
    Hanak SE, Reilly EM, Wotanis J, Zhu B, Pulicicchio C, McMonagle-Strucko K, Wettstein JG, Black MD.
    J Pharmacol Exp Ther; 2004 Jan 31; 308(1):214-20. PubMed ID: 14566007
    [Abstract] [Full Text] [Related]

  • 59. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.
    Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE.
    J Exp Med; 2004 Dec 20; 200(12):1667-72. PubMed ID: 15611292
    [Abstract] [Full Text] [Related]

  • 60. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A, Butzkueven H, Kolbe S, Marriott M, Alexandrou E, Gresle M, Egan G, Kilpatrick T.
    Pharmacol Ther; 2010 Apr 20; 126(1):82-93. PubMed ID: 20122960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.